How Cytokines Co-occur across Rickettsioses Patients: From Bipartite Visual Analytics to Mechanistic Inferences of a

Suresh K Bhavnani1, Justin Drake, Gowtham Bellala

  • 1Inst. for Translational Sciences, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX;

Insights

Rickettsial diseases like Mediterranean Spotted Fever (MSF) and DEBONEL involve cytokine storms. This study identifies distinct cytokine patterns in MSF patients, suggesting pathways for therapeutic targets.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Molecular Biology

Background:

  • Rickettsial diseases, including Mediterranean Spotted Fever (MSF) and Dermacentor spp.-borne necrosis-erythema lymphadenopathy (DEBONEL), are re-emerging.
  • These infections can cause severe endothelial damage, microvascular leakage, high morbidity, and mortality.
  • The molecular pathways underlying human responses to rickettsiae remain poorly understood.

Purpose of the Study:

  • To analyze co-occurring cytokine profiles in patients with acute localized (DEBONEL) versus systemic (MSF) rickettsiosis.
  • To elucidate the molecular pathways triggered by rickettsial infections in humans.
  • To generate a hypothesis for rickettsia-induced cytokine storm mechanisms and identify potential therapeutic targets.

Main Methods:

  • Bipartite visual analytics were employed to examine cytokine co-occurrence patterns.
  • Candidate cytokines were analyzed in acutely ill patients diagnosed with either MSF or DEBONEL.
  • Patient cytokine expression levels were compared between localized and systemic forms of rickettsiosis.

Main Results:

  • A distinct network core of MSF patients showed high expression of cytokines related to microvascular leakage, endothelial repair, and inflammation.
  • A network periphery comprised both MSF and DEBONEL patients with lower overall cytokine expression.
  • Evidence suggests specific cytokine pathways are activated in systemic rickettsiosis.

Conclusions:

  • The study provides insights into human molecular responses to rickettsial infections.
  • Distinct cytokine profiles differentiate systemic (MSF) from localized (DEBONEL) rickettsiosis.
  • Findings support a hypothesis of rickettsia-induced cytokine storms and highlight potential therapeutic targets.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
56
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K